MedPath

A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine

Phase 2
Suspended
Conditions
HIV Infections
Registration Number
NCT00002424
Lead Sponsor
Merck Sharp & Dohme LLC
Brief Summary

This study will see how safe and effective against HIV the drugs L-756423 plus indinavir (IDV) are compared to just IDV when taken with stavudine (d4T) and lamivudine (3TC). The study will also see whether taking 1 large dose of L-756423/IDV once a day is as safe and effective as taking 2 smaller doses twice a day.

Detailed Description

Patients are randomized to 1 of 4 treatment arms. In Group 1, patients receive a dose of L-756423/IDV once daily plus IDV placebo. In Group 3, patients receive a lower dose of L-756423/IDV twice daily (with the daily dosage equaling that of Group 1) plus IDV placebo. In Groups 2 and 4, patients receive equal dosages of IDV plus L-756423/IDV placebo. In all 4 groups L-756423 and IDV are blinded to the investigator and patient. All groups receive open-label d4T and 3TC. Patients routinely undergo a physical exam and have blood and urine tests to ensure the drugs' safety and tolerability, which will be evaluated by tabulation of adverse events and clinical assessment of laboratory data. In addition, CD4+ T cell and plasma viral RNA levels are measured to quantify the drugs' antiretroviral activity.

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
186
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (16)

UCLA School of Medicine / Ctr for Research and Education

🇺🇸

Los Angeles, California, United States

Associates in Research

🇺🇸

Fort Myers, Florida, United States

Rush Presbyterian - Saint Luke's Med Ctr

🇺🇸

Chicago, Illinois, United States

SUNY at Stony Brook / Div of Infectious Disease

🇺🇸

Stony Brook, New York, United States

Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ

🇺🇸

New York, New York, United States

Univ of Miami School of Medicine

🇺🇸

Miami, Florida, United States

Henry Ford Hosp

🇺🇸

Detroit, Michigan, United States

Beth Israel Deaconess Med Ctr

🇺🇸

Boston, Massachusetts, United States

Georgetown Univ Med Ctr

🇺🇸

Washington, District of Columbia, United States

Univ of Kentucky Med Ctr

🇺🇸

Lexington, Kentucky, United States

ViRx / Dupont Circle Physicians Group

🇺🇸

Washington, District of Columbia, United States

Univ of Kentucky

🇺🇸

Lexington, Kentucky, United States

NYU Med Ctr / C & D Building

🇺🇸

New York, New York, United States

Grady Mem Hosp

🇺🇸

Atlanta, Georgia, United States

The Miriam Hosp

🇺🇸

Providence, Rhode Island, United States

The CORE Ctr

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath